Screening for Hepatitis D Virus in HIV and HBV Coinfected Individuals

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the prevalence and disease burden of hepatitis delta virus (HDV) among individuals who are coinfected with HIV and hepatitis B virus (HBV) in Hong Kong. It will involve a cross-sectional analysis of individuals living with these infections, focusing on those with chronic HBV and related health complications. The study seeks to fill the gap in existing data regarding HDV in this specific population, which is crucial for understanding the overall impact of these infections.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Individuals with HIV infection, i.e. anti-HIV or HIV RNA positive; AND
2. Individuals with chronic hepatitis B, i.e. hepatitis B surface antigen (HBsAg) or HBV DNA positive for two times at least 6 months apart; AND
3. Aged 18 years old or above.
4. Written or verbal consent obtained

Exclusion Criteria:

1. Refusal to consent
2. Age \< 18 years

Where it's running

• The Chinese University of Hong Kong
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Lai Hung Grace Wong — Chinese University of Hong Kong
• Study coordinator: Angel Chim
• Email: angelchim@cuhk.edu.hk
• Phone: +85235054205

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Germinal center immune response in chronic hepatitis B

  We will see if the structure and B-cell activity in germinal centers differ between people with chronic hepatitis B and people without by analyzing blood and discarded surgical tissues.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07240350

• GIGA-2339: safety and drug behavior testing in people with chronic hepatitis B

  This trial tests single and multiple IV doses of GIGA-2339 versus placebo to see if they are safe and well tolerated in adults with chronic hepatitis B.

  Recruiting at 19 sites Phase 1 GigaGen, Inc. · Chandler, Arizona and 19 other locations · NCT07024641

• Hepatitis B vaccination for newborns after surgery

  This study looks at how safe and effective it is to give hepatitis B vaccinations to newborns who have had surgery, to help find the best timing for these shots.

  Recruiting Children's Hospital of Chongqing Medical University · Chongqing, Chongqing Municipality · NCT06023056

• Registry for patients with hepatitis B virus infection

  This study is collecting information from people with hepatitis B to better understand the virus and find out who might be interested in trying new treatments like vaccines.

  Recruiting Hannover Medical School · Hanover · NCT05051098

• Evaluating new biomarkers for chronic Hepatitis B infection management

  This study is testing new blood markers to see if they can help doctors better manage chronic Hepatitis B and predict serious health issues for patients receiving care at a hospital.

  Recruiting Assistance Publique - Hôpitaux de Paris · Créteil, Créteil · NCT06906016

• Non-invasive approach to assess liver fibrosis in chronic hepatitis B patients

  This study is testing a new way to see if liver stiffness measurements can help predict if liver damage improves in people with chronic hepatitis B who have been treated with antiviral therapy.

  Recruiting Beijing Friendship Hospital · Beijing · NCT06874127

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.